Effectiveness and tolerability of therapy with exenatide once weekly vs basal insulin among injectable‐drug‐naïve elderly or renal impaired patients with type 2 diabetes in the United States

類似資料

• Effectiveness and Tolerability of Therapy With Once-Weekly Exenatide Versus Basal Insulin Among Injectable-Naive Patients With Type 2 Diabetes in a Real-World Setting in the United States
  著者:: Loughlin, Anita M., 等
  出版事項: (2018)
• Tolerability and Effectiveness of Exenatide Once Weekly Relative to Basal Insulin Among Type 2 Diabetes Patients of Different Races in Routine Care
  著者:: Nunes, Anthony P., 等
  出版事項: (2017)
• Efficacy and safety of exenatide once‐weekly vs exenatide twice‐daily in Asian patients with type 2 diabetes mellitus
  著者:: Ji, Linong, 等
  出版事項: (2013)
• Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly alone, or dapagliflozin alone added to metformin monotherapy in subgroups of patients with type 2 diabetes in the DURATION‐8 randomized controlled trial
  著者:: Frías, Juan P., 等
  出版事項: (2018)
• Exenatide once weekly: clinical outcomes and patient satisfaction
  著者:: Biju Jose1, 等
  出版事項: (2010-08-01)